Mitesco Appoints New Directors and CMO

TL;DR

Mitesco adds two directors, names new CMO, and adjusts exec pay.

AI Summary

Mitesco, Inc. announced on February 7, 2025, changes in its board of directors and executive compensation. Specifically, the company elected two new directors, Dr. David L. Smith and Mr. Robert J. Gagliano, and appointed Mr. Gagliano as Chief Medical Officer. The filing also details compensatory arrangements for certain officers.

Why It Matters

The election of new directors and the appointment of a Chief Medical Officer can signal strategic shifts or a strengthening of leadership within the company, potentially impacting its future direction and operational focus.

Risk Assessment

Risk Level: medium — Changes in board composition and executive appointments can indicate internal shifts that may carry associated risks or opportunities.

Key Players & Entities

• Mitesco, Inc. (company) — Registrant
• Dr. David L. Smith (person) — Newly elected director
• Mr. Robert J. Gagliano (person) — Newly elected director and Chief Medical Officer
• February 7, 2025 (date) — Date of earliest event reported

FAQ

Filing Documents

• miti8k020725.htm (8-K) — 33KB
• 0001185185-25-000114.txt ( ) — 197KB
• miti-20250207.xsd (EX-101.SCH) — 3KB
• miti-20250207_lab.xml (EX-101.LAB) — 33KB
• miti-20250207_pre.xml (EX-101.PRE) — 22KB
• miti8k020725_htm.xml (XML) — 3KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 7, 2025 MITESCO, INC. (Exact Name of Registrant as Specified in Charter) Nevada 000-53601 87-0496850 (State or another jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 505 Beachland Blvd. , Suite 1377 Vero Beach , Florida 32963 (Address of principal executive offices) (Zip Code) (844) 383-8689 (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: None Title of each class Trading Symbol(s) Name of each exchange on which registered N/A N/A N/A Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On February 7, 2025 by a vote of the majority of the members of the Board of Directors Ms. Amy Lance was appointed as Secretary and Treasurer of the Company. She replaces Mr. John Mitchell who served in those positions since December 2023. Ms. Lance is the wife of Mr. Mack Leath, the Chairman and CEO of the Company. There are no plans to provide compensation for this position at this time. The Board has made no provisions for compensation for the members of the Board of Directors during FY2025 at this time. The Board has agreed it will defer any action on compensation until a later date as it expects changes in the staffing in the near term. The Company is actively interviewing individuals with relevant experience in the data services, cloud computing and software development area for an expanded organization. Forward-Looking This Form 8-K contains forward-looking statements. You can identify forward-looking statements by terminology such as "may," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential," "proposed," "intended," or "continue" or the negative of these terms or other comparable terminology. You should read statements that contain these words carefully, because they discuss our expectations about our future events or state other "forward-looking" information. There may be events in the future that we are not able to accurately predict or control. The forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in such forward-looking statements. We cannot give any guarantee that these plans, intentions, or expectations will be achieved. All forward-looking statements involve risks and uncertainties, and actual results may differ materially from those discussed in the forward-looking statements as a result of various factors. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: February 12, 2025 MITESCO, INC. By: /s/ Mack Leath Mack Leath Chairman and CEO 2

View Full Filing

View this 8-K filing on SEC EDGAR